Erectile dysfunction affects an estimated 4.3 million men in the United Kingdom, according to data cited by the Sexual Advice Association. The true prevalence is likely higher: ED remains significantly underreported, with many men reluctant to discuss it with any healthcare professional.
The reclassification of sildenafil 50mg to pharmacy (P medicine) status in March 2018 — marketed as Viagra Connect — was a significant step in improving access. Community pharmacists can now supply the most widely prescribed ED treatment without a prescription, subject to a structured clinical assessment. This places pharmacy at the front line of men's sexual health.
Why pharmacy supply matters
Before reclassification, men with ED had three options: see their GP, buy from an online prescriber (of variable quality), or purchase counterfeit medicines. The MHRA estimates that up to 2 million men in the UK have used counterfeit or unlicensed ED medicines, many purchased online without clinical assessment.
Pharmacy supply provides a safe, face-to-face clinical consultation with a regulated healthcare professional. It is also an opportunity to identify undiagnosed cardiovascular disease — ED is increasingly recognised as an early marker of vascular dysfunction.
Sildenafil 50mg: pharmacy supply protocol
Who can be supplied
| Criterion | Detail |
|---|---|
| Age | 18 years and over |
| Gender | Men only (biological males) |
| Condition | Erectile dysfunction — defined as persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity |
| Duration | Symptoms for at least 3 months (to exclude transient situational ED) |
Who must NOT be supplied (refer to GP)
| Exclusion | Reason |
|---|---|
| Current nitrate therapy (GTN, isosorbide mononitrate/dinitrate) | Life-threatening hypotension |
| Nicorandil | Nitrate-like vasodilatory effect |
| Recent cardiovascular event (MI, stroke, angina) within 6 months | Needs cardiological assessment before PDE5 inhibitor use |
| Severe hepatic impairment | Reduced sildenafil metabolism |
| Hypotension (systolic <90mmHg) | Risk of symptomatic hypotension |
| Conditions where sexual activity is medically inadvisable | Unstable angina, severe heart failure |
| Anatomical deformation of the penis (Peyronie's disease) or conditions predisposing to priapism (sickle cell disease, multiple myeloma, leukaemia) | Specialist assessment required |
| Currently on alpha-blockers (doxazosin, tamsulosin) without GP review | Hypotension risk — can be managed with dose spacing, but needs prescriber input |
| Currently on strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, erythromycin, clarithromycin) | Increased sildenafil levels |
Counselling points
- Timing: take 1 hour before sexual activity. Effective for up to 4–5 hours
- Food: high-fat meals delay absorption by up to 1 hour. Light meal or empty stomach preferred
- Alcohol: moderate alcohol is acceptable. Excessive alcohol worsens ED and may reduce sildenafil efficacy
- Dose: 50mg is the pharmacy supply dose. If ineffective after 4 attempts, refer to GP for possible dose increase (100mg) or alternative PDE5 inhibitor
- Frequency: maximum once daily
- Side effects: headache, flushing, nasal congestion, dyspepsia, visual disturbance (blue tinge — PDE6 cross-reactivity). Usually mild and transient
- Priapism warning: an erection lasting more than 4 hours is a medical emergency — seek immediate hospital attention
ED as a cardiovascular marker
This is perhaps the most clinically important aspect of pharmacy ED consultations. Erectile dysfunction shares the same vascular pathophysiology as coronary artery disease, peripheral vascular disease and stroke. The endothelial dysfunction that causes ED typically precedes symptomatic cardiovascular disease by 3–5 years, according to a landmark 2005 meta-analysis in the European Heart Journal.
A man presenting to the pharmacy with ED who has:
- Uncontrolled hypertension
- Elevated BMI
- Smoking history
- Family history of cardiovascular disease
- Diabetes
...should be counselled that ED may be an early warning sign of cardiovascular risk, and encouraged to see his GP for cardiovascular risk assessment, including blood pressure, cholesterol and HbA1c.
This is a conversation that many men will have only in the pharmacy — they may never raise it with their GP. The pharmacist's willingness to broach the cardiovascular angle, sensitively and factually, can be genuinely life-saving.
Lifestyle advice
Evidence-based recommendations pharmacists can offer:
- Exercise: regular aerobic exercise improves erectile function — a 2018 meta-analysis in Sexual Medicine Reviews found significant benefit across 10 RCTs
- Weight loss: obesity is an independent risk factor for ED. Losing 5–10% of body weight can improve erectile function
- Smoking cessation: smoking directly damages endothelial function. Quitting improves vascular health within months
- Alcohol moderation: chronic heavy drinking impairs sexual function independently of cardiovascular effects
- Sleep: sleep apnoea is associated with ED — men reporting excessive daytime sleepiness alongside ED should be asked about snoring and witnessed apnoeas
- Mental health: anxiety and depression are major contributors to ED. Pharmacists should normalise this and encourage GP consultation if psychological factors appear predominant
Other PDE5 inhibitors (prescription only)
| Medicine | Onset | Duration | Key difference |
|---|---|---|---|
| Tadalafil 10–20mg | 30 min | Up to 36 hours | Longer duration. Also available as 5mg daily for continuous effect |
| Vardenafil 5–20mg | 25–60 min | 4–5 hours | Slightly faster onset than sildenafil in some studies |
| Avanafil 50–200mg | 15–30 min | 6–12 hours | Fastest onset. Most selective for PDE5 |
For men who have tried sildenafil without adequate response, or who prefer a longer-acting option, referral to the GP for tadalafil or an alternative is appropriate.
When to refer
- Sildenafil ineffective after 4 attempts at 50mg
- Any cardiovascular symptoms (chest pain, breathlessness on exertion, palpitations)
- ED with loss of morning erections and reduced libido (possible hypogonadism — needs testosterone level check)
- Psychological distress related to ED
- Peyronie's disease (penile curvature or plaques)
- ED following pelvic surgery or radiotherapy
The pharmacy opportunity
ED consultations are among the most impactful interactions a community pharmacist can have. The clinical assessment protects patients from drug interactions and undiagnosed cardiac risk. The cardiovascular screening opportunity is genuinely preventive. And the simple act of providing a safe, non-judgemental environment for a conversation that many men find deeply difficult has inherent therapeutic value.
For pharmacists seeking specialist sexual health or men's health roles, PharmSee's job search tracks vacancies, and the salary guide provides pay context across NHS bands.
Data sources: MHRA sildenafil reclassification (2018), Sexual Advice Association prevalence estimates, NICE CKS Erectile Dysfunction, European Heart Journal ED-cardiovascular meta-analysis, PharmSee vacancy tracker (April 2026, 1,715 active roles).